ImmitraBio
Immitra Bio is developing a platform for scalable, one-time curative in-vivo gene editing therapies based on its novel mutation agnostic gene editing technology and digital target identification platform.
ImmitraBio has raised €2.6M across 1 funding round from 9 investors, most recently a round in Jul 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Zurich, Switzerlandimmitrabio.com ↗
Total raised
€2.6M
€2,592,073
Funding rounds
1
Investors
9
distinct backers
Active since
2026-07
latest 2026-07
Funding by year
EUR raised per year · 2026 YTDImmitraBio — funding by year — interactive chart.
Data table
| ImmitraBio — funding by year | |
|---|---|
| 2026 | €2.6M |
Signals
High confidenceRaise-next likelihood17
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-21 | Other | €2.6M | another.vc,BackBone Ventures,ETH Foundation,Fongit,KickFund,OCCIDENT+3 more | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData